EarlySign Signs Agreement with Roche on AI Solution for Early Lung Cancer Detection
Medial EarlySign signed a new partnership with Roche to create innovative, evidence-based solutions for early detection of lung cancer.
Read MorePosted by Andy Lundin | Jul 7, 2022 | Company News, Lung Cancer |
Medial EarlySign signed a new partnership with Roche to create innovative, evidence-based solutions for early detection of lung cancer.
Read MorePosted by Andy Lundin | Jul 6, 2022 | Covid 19 |
Scientists developed a COVID test that can identify, in just a few hours, which variant has infected a patient.
Read MorePosted by Andy Lundin | Jul 5, 2022 | Diabetes & Metabolic Diseases |
In a study led by MedUni Vienna, a new method has now been used to determine alcohol consumption in fatty liver disease.
Read MorePosted by Andy Lundin | Jul 1, 2022 | Infectious Diseases |
New research shows that machine-learning algorithms can help distinguish between acute cholangitis and alcohol-associated hepatitis.
Read MorePosted by Chris Wolski | Jun 30, 2022 | Emerging & Zoonotic Diseases |
Anitoa’s monkeypox PCR test is designed to be carried out on-site, near patient, avoiding the need to transport patient samples to labs.
Read More